Management of Hypertension in Athletes
Athletes have a lower incidence of high blood pressure than nonathletes, but the prevalence of hypertension among athletes is only 50% less than that in the general population . Further, the risk of hypertension may actually be increased in some athletes and physically active individuals because of increased body mass. Indeed, hypertension is the most common cardiovascular problem in athletes.
KeywordsCalcium Channel Blocker Renal Artery Stenosis Loop Diuretic Target Organ Damage Secondary Hypertension
- 4.Hanson P, Andrea BE. Treatment of hypertension in athletes. In:a DeLee J. Drez D. Starits ki CL, eds. Orthopaedic Sports Medicine: Principles and Practice. Philadelphia, Saunders, 1994:307–319.Google Scholar
- 10.USADA guide to prohibited classes of substances and prohibited methods of doping. www. 2008. 10-3-2001.
- 11.Fuentes RJ, Rosenberg JM. Athletic drug reference “99: complies with NCAA and USOC rules. Clean Data. Durhan, NC, Glaxco Wellcome. 2008:28–36, 52–54, 317–408.Google Scholar
- 12.IOC prohibited classes of substances and prohibited methods of doping. 10-2-2001.Google Scholar
- 13.SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265(24):3255–3264.Google Scholar
- 14.Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996;276(23):1886–1892.PubMedCrossRefGoogle Scholar
- 15.Philipp T, Anlauf M, Distler A, Holzgreve H, Michaelis J, Wellek S. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group. BMJ 1997;315(7101):154–159.PubMedCrossRefGoogle Scholar
- 21.ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2000;283(15):1967–1975.Google Scholar